Yoosun Lee^1*, Junghyun Yoon, MPH^2*, Boyoung Park, MD, PhD^3* and Hyeon-Seok Eom, MD, PhD^4*

¹Medical Affairs, Janssen Korea, Seoul, Korea, Republic of (South)
²Department of Health Sciences, Hanyang University, Seoul, Korea, Republic of (South)
³Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea, Republic of (South)
⁴Department of Internal Medicine, Center for Hematologic Malignancy, National Cancer Center, Goyang-Si, Korea, Republic of (South)

Kaitlyn C Dykes, MD, BS^1,2, Jiling Chou, MA^3*, Allison Taylor, MD, MS⁴, MA Xiaoyang^3* and Catherine Lai, MD, MPH⁵

¹Department of Internal Medicine, MedStar Georgetown University Hospital, San Diego, CA
²UC San Diego Medical Center, San Diego, CA
³Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA, Washington DC, DC
⁴Internal Medicine, Duke University School of Medicine, Durham
⁵Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA

Othman Salim Akhtar, MD¹, Andrea Anampa-Guzman, MD^1*, Matthew J Cortese, MD, MPH¹, Alankrita Taneja, MBBS¹, Sheeba Ba Aqeel, MD², Paola Ghione, MD³, Francisco Hernandez-Ilizaliturri, MD⁴ and Pallawi Torka, MD¹

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Roswell Park Comprehensive Cancer Center, New York, NY
⁴Roswell Park Cancer Institute, Buffalo, NY

Sumit Gupta, MD, PhD^1,2,3, Qing Li, MSc^4*, Paul Nathan, MD^1,3,5*, Norma D'Agostino^6*, Nancy N Baxter, MD, PhD^7*, Colleen Fox, BSc, MSc^8*, Natalie Coburn, MD^9* and Rinku Sutradhar, PhD^10*

¹Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
²Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
³Faculty of Medicine, University of Toronto, Toronto, ON, Canada
⁴Institute for Clinical Evaluative Sciences, Toronto, Canada
⁵Division of Haematology/Oncology, Hospital For Sick Children, Toronto, ON, Canada
⁶University Health Network, Toronto, Canada
⁷University of Melbourne, Melbourne, Australia
⁸Ontario Health, Toronto, ON, Canada
⁹Sunnybrook Hospital, Toronto, Canada
¹⁰Cancer Research Program, ICES, Toronto, ON, Canada

Lucía Castilla García^1*, Sergio Ramos Cillán^2*, Alberto Lopez García, MD^2*, Natalia Barreras Ruiz^3*, Eva Castillo Bazan^3*, Adriana Pascual^4*, Miriam Riesco Ovelar^5*, Celia Urrutia^5*, Susana Cruz^6*, Alberto Pardo^7*, Antonio Herrero^8*, Maria Angeles Perez Saenz, MD^9*, Daniel Morillo Gilles^2*, María Pilar Llamas Sillero, MD, PhD^10,11*, Javier Becares^3*, Carla Barriocanal^12*, Jorge Short Apellaniz^12*, Marta del Olmo^12*, Javier Arcos Campillo^12* and Raul Cordoba, MD, PhD¹³

¹Department of Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
²Fundación Jimenez Díaz University Hospital, Madrid, Spain
³Department of Pharmacy, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁴Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁵Oncohealth Institute, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁶Information and Communication technology (ICT) department., Fundación Jimenez Díaz University Hospital, Madrid, Spain
⁷Information and Communication technology (ICT) department., Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁸Information and Communication Technology (ICT) Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain
⁹Haematology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, ESP
¹⁰Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹¹Department of Hematology, Fundación Jiménez Díaz University Hospital, Madrid, Spain
¹²Clinical and Organizational Innovation Unit (UICO); QUIRONSALUD PUBLIC HOSPITALS NETWORK, Madrid, Spain
¹³Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain

Stefan K. Barta, MD¹, Nicholas Liu, PharmD^2*, Maral DerSarkissian, PhD^3,4*, Rose Chang, MSPH, MS, ScD^4*, Mingchen Ye, MS^4*, Mei Sheng Duh, ScD, MPH⁴, Andy Surinach, MPH^5*, Michelle A. Fanale, MD² and Kristina S. Yu, PhD, MPH, RPh^2*

¹Perelman Center for Advanced Medicine, Philadelphia, PA
²Seagen Inc., Bothell, WA
³Analysis Group, Inc., Los Angeles, CA
⁴Analysis Group, Inc., Boston, MA
⁵Genesis Research, Hoboken, NJ

Ashley E. Rosko, MD¹, Kaitlyn Dvorak, PhD^2*, Qiuhong Zhao, MS^1*, Electra Paskett^3*, Samantha Jaglowski, MD, MPH⁴, James L. Fisher, PhD^4*, Jessica Krok-Schoen^5*, Francesca Cottini, MD⁶, Abdullah Khan, MBBS, MSc⁷, Srinivas Devarakonda, MD⁸, Naresh Bumma, MD⁹, Elvira Umyarova, MD¹⁰, Nidhi Sharma, PhD^4*, Don M. Benson Jr., MD¹¹ and Jesse Plascak, PhD^12*

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²The Ohio State Univeristy, Columbus, OH
³Division of Cancer Prevention and Control, Department of Internal Medicine, Coll, Columbus, OH
⁴The Ohio State University, Columbus, OH
⁵Ohio State University, Columbus, OH
⁶Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
⁷Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁸The Ohio State University Wexner Medical Center, Columbus, OH
⁹Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁰Division of Hematology, The Ohio State University, Columbus, OH
¹¹Riney Family Myeloma Center for Research Excellence, The Ohio State University Medical Center, Columbus, OH
¹²Division of Cancer Prevention and Control, The Ohio State University, Columbus, OH

Sheeba Ba Aqeel, MD¹, Othman Salim Akhtar, MD^1,2, Arya Mariam Roy, MBBS¹, Alankrita Taneja, MBBS¹, Richa Parikh, MD³, Muhammad Salman Faisal, MD, MBBS¹, Hassan Awada, MD^1*, Andrea Anampa-Guzman, MD^1*, Matthew J Cortese, MD, MPH¹, Francisco Hernandez-Ilizaliturri, MD¹ and Pallawi Torka, MD¹

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Moffitt Cancer Center, Buffalo, NY
³Department of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI

Taiga Nishihori, MD¹, Doris K. Hansen, MD¹, Hien D. Liu, MD¹, Omar Alexis Castaneda Puglianini, MD², Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP², Brandon J. Blue, MD³, Jason Brayer, MD, PhD⁴, Jongphil Kim, PhD^5*, Ariel F Grajales-Cruz, MD⁴, Jose Ochoa, MD¹, Rachid C. Baz, MD⁶, Kenneth H. Shain, MD, PhD⁴, Frederick L. Locke, MD⁷ and Melissa Alsina, MD**⁸

¹Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
²Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁵Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institutte, Tampa, FL
⁶Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL
⁷H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁸Moffitt Cancer Center, Tampa, FL

Naveen G Subramanian, MD^1*, Fleur M. Aung, MD², Krina Patel, MD, MSc³, Hans C. Lee, MD⁴, Shida Jin^5*, Elliana Young, MS^6* and Cristhiam Mauricio Rojas Hernandez, MD⁷

¹Internal Medicine Residency, UTHealth McGovern Medical School, Austin, TX
²Department of Laboratory Medicine, Section of Transfusion Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁵Enterprise Integration & Development, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Enterprise Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX

Audrey M. Sigmund, MD¹, Michelle Fullmer, APRN-CNP^1*, Rina Li, MPH^1*, Tracelyn Freeman, PharmD, BCOP^1*, Bryant Clemons, PharmD^1*, Stefanie Quimjian, APRN-CNP^1*, Heather Niccum Haag, BSN, RN, CCRN^2*, Ai Ni, PhD^3*, Shuiying Hu, PhD^4*, Alice S. Mims, MD¹, Gretchen A. McNally, PhD, ANP^1*, Maryam Lustberg, MD^5* and Bhavana Bhatnagar, DO⁶

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²Division of Nursing, Department of Neuro-Oncology, The Ohio State University, Columbus, OH
³Department of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH
⁴Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH
⁵Director Yale Breast Center, Comprehensive Yale Cancer Center, New Haven, CT
⁶Department of Hematology and Medical Oncology, West Virginia University Cancer Institute, Wheeling, WV

Ugochi Ebinama, MD¹, Ajay Sheshadiri, MD^2*, Sairah Ahmed, MD³, Hun Ju Lee, MD⁴, Meng Liu^5* and Swaminathan Padmanabhan Iyer, MD^6*

¹University of Texas Health Sciences Center Houston, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
⁴University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Industrial Engineering, Penn State University, State College, PA, Philadelphia, PA
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Perla R. R. Colunga-Pedraza, MD¹, Andres Gomez-De Leon, MD², Christianne Bourlon De Los Rios, MD, MSc³, Cesar Omar Vargas-Serafin, MD^4*, Myrna Patricia Pequeño Luevano, MD^5*, Lauro Fabian Amador^6*, Carolina García-Castillo, MD^7*, Martha Alvarado, MD^8*, Guillermo José Ruiz-Argüelles, MD, FRCP (Glasg), MACP, DSc(hc), FRCP⁹, Alberto Olaya-Vargas, MD; M.Sc^10*, Samantha P. Peña-Lozano, MD^11*, Guadalupe González Villarreal, MD^12*, Elías Eugenio González López, MD^13*, Gabriela Cardoso Yah^14*, Ivan Murrieta-Alvarez, MD^15*, Luis Mario Villela Martinez, MD, MSc^16* and David Gomez Almaguer, MD^17,18*

¹Servicio de Hematología, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, NL, Mexico
²Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González., Monterrey, Mexico
³Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
⁴Department of Hematology and Oncology, Instituto Nacional De Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico
⁵Hematopoietic stem cell Unit IMSS UMAE 25, IMSS UMAE 25, Monterrey, MEX
⁶Hospital Regional de Alta Especialidad del Bajio, León, Mexico
⁷Hematología, Hospital Central Militar, SEDENA, Ciudad de México, Mexico
⁸Centro Medico Nacional 20 de Noviembre, Mexico City, Mexico
⁹Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, PU, Mexico
¹⁰Division of Hematology/Oncology, Bone Marrow Transplant unit, National Pediatrics Institute, Ciudad de México, Mexico
¹¹UniversidadUniversidad Autónoma de Nuevo León, Servicio de Hematología, Hospital Universitario “Dr. José E. González”, Monterrey, NL, Mexico
¹²Hematopoietic stem cell Unit IMSS UMAE 25, IMSS UMAE 25, Monterrey, NL, Mexico
¹³Escuela de Medicina y Ciencias de la Salud, Tec de Monterrey, Campus Monterrey, Monterrey, NL, Mexico
¹⁴Hospital Central Militar, SEDENA, Ciudad De Mexico, MEX
¹⁵Centro de Hematología y Medicina Interna de Puebla, Puebla, PU, Mexico
¹⁶Escuela de Medicina Del Tecnológico de Monterrey, Hermosillo, SO, Mexico
¹⁷Universidad Autónoma de Nuevo León, Servicio de Hematología, Hospital Universitario “Dr. José E. González”, Monterrey, NL, Mexico
¹⁸Gomez Almaguer Clinica de Hematologia, Monterrey, Mexico

Meredith Jackson^1*, Heather Reves, MS, BS^2*, Tanushree Prasad, MA^3*, Akshat M Patel, BA⁴, Aimaz Afrough, MD⁵, Larry D. Anderson Jr., MD, PhD⁶, Stephen S. Chung, MD⁵, Robert H. Collins, M.D.⁷, Gurbakhash Kaur, MD^5,8, Kiran A Kumar, MD, MBA^9*, Yazan F. Madanat, MD⁷, Madhuri Vusirikala, MD^10*, Farrukh T. Awan, MD^5,7 and Praveen Ramakrishnan Geethakumari, MD, MS¹¹

¹Internal Medicine, UT Southwestern Medical Center, Dallas, TX
²Division of Hematologic Malignancies, UT Southwestern Medical Center, Dallas, TX
³Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas
⁴Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
⁵Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁶Cellular Therapy and Hematologic Malignancies Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁷Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
⁸Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁹Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX
¹⁰Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
¹¹Division of Hematologic Malignancies and Stem Cell Transplantation, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

Heather S. L. Jim, PhD^1*, Aasha I. Hoogland, PhD^2*, Jennifer M. Logue, MD, BS, BA³, Briana Aguilar^4*, Xiaoyin Li, PhD^5*, Julia Thornton Snider, PhD^6*, Sally West Wade^7*, Christine T Fu, PhD^8*, Julio C. Chavez, MD⁹, Michael D. Jain, MD, PhD¹⁰, Aleksandr Lazaryan, MD, PhD, MPH¹¹, Bijal D. Shah, MD¹² and Frederick L. Locke, MD¹³

¹Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL
²Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institution, Tampa, FL
⁴Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
⁵Moffitt Cancer Center, Tampa, FL
⁶Kite, a Gilead Company, Santa Monica, CA
⁷Kite Pharma, Salt Lake City, UT
⁸Kite Pharma, Santa Monica, CA
⁹Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁰Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
¹¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹²Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
¹³Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Krish Patel, MD¹, Jakub Svoboda, MD², Bijal D. Shah, MD³, Bruce D. Cheson, MD⁴, Georges Azzi, MD^5*, Kashyap Patel, MD^6*, Andrew J Cowan, MD⁷, Lori Muffly, MD⁸, Heidi Simmons, PhD⁹, Mark Schliekelman, PhD^9* and Jessica Leonard, MD¹⁰

¹Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle
²Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁴Lymphoma Research Foundation, New York
⁵Sylvester Cancer Center, Miami, FL
⁶Carolina Blood and Cancer Care Associates, Rock Hill, SC
⁷Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁸Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁹Adaptive Biotechnologies, Seattle, WA
¹⁰Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR

Snegha Ananth, MBBS¹, Supreet Kaur, MD², Alaq Al-Abayechi, MD^1*, Jean Pierre Blaize, MD³, Lauren Diaz Boyle, DO^4*, Lakene Raissa Djoufack Djoumessi, MD⁵, Manuel Espinoza Gutarra, MD^6*, Kathleen Franklin, RN^1*, Lindsey Lu, PharmD^1*, Kana Tai Lucero^1*, Phillip Nazarewicz, BS^1*, Abhishek Pandya, DO^7,8, Gabriel Roman Souza, MD⁸, Michael M. Song, MD, PhD, PharmD⁹, Brian Warnecke, DO^10*, Jennifer Whitehead, MS^1*, Madison H. Williams, MD¹¹, Ryan A. Williams, MD¹¹, Michael Mader, MS^1* and Zohra Nooruddin, MD¹

¹South Texas Veterans Health Care System, San Antonio, TX
²UT Health Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio
³Augusta Oncology, Augusta, Georgia
⁴Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX
⁵National Institute of Health, Bethesda, MD
⁶O'neal Comprehensive Cancer Center, Birmingham, AL
⁷University of Texas Health Science Center at San Antonio, San Antonio, TX
⁸University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
⁹Baylor College of Medicine, Houston, TX
¹⁰University of California, Irvine, Irvine, CA
¹¹University of Texas MD Anderson Cancer Center, Houston, TX

Emmanuel Bachy, MD, PhD^1*, Gandhi Laurent Damaj, MD, PhD^2*, Qiufei Ma^3*, Christian Hampp^3*, James Harnett^3*, Rachel E. Sobel^3*, Jessica J. Jalbert, PhD^3*, Ruben G.W. Quek^3*, Wenhui Wei, PhD^3*, Ning Wu^3*, Vera Mastey^3*, Joy Wang^3*, Anit Bajwa^3*, Benedikt Maissenhaelter^4*, Chantal van Gils^5*, Shivani Aggarwal^6*, Aafia Chaudhry, MD, MBA, MS^3*, Hesham Mohamed, MD^3*, Srikanth R. Ambati, MBBS, MD^3* and Catherine Thieblemont, MD, PhD⁷

¹Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
²Institut d'Hematologie de Basse-Normandie, CHU Cote de Nacre, Université de Normandie, Caen, France
³Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁴IQVIA, Munich, Germany
⁵IQVIA, Rotterdam, Netherlands
⁶IQVIA, Los Angeles, CA
⁷Université de Paris, Assistance Publique – Hôpitaux de Paris, Hopital Saint-Louis, Hemato-Oncologie, Paris, France

Brian J Scott, MD^1*, Tracy Murray, NP^2*, Gayle K Deutsch, PhD, ABPP^2*, Sheila Lahijani, MD^3*, Matthew J Frank, MD, PhD⁴ and Michelle Monje, MD, PHD^5*

¹Department of Neurology, Neuro-Immuno-Oncology, Stanford University, San Francisco, CA
²Stanford University, Palo Alto, CA
³Division of Psychiatry and Behavioral Sciences, Stanford University Hospital, Stanford, CA
⁴Center for Cancer Cell Therapy, Stanford University School of Medicine, Palo Alto, CA
⁵Stanford University School of Medicine, Palo Alto, CA

Aishwarya Sannareddy, MBBS^1*, Heather Reves, MS, BS^2*, Kefyalew Jaleta, MT (ASCP)^3*, Ramyakumari .Ramiahsankarasubramanian, MBBS^3*, Hetalkumari Patel, PharmD, BCOP^4*, Madhusudhanan Narasimhan, PhD^5*, Larry D. Anderson Jr., MD, PhD⁶, Aimaz Afrough, MD⁷, Stephen S. Chung, MD⁸, Robert H. Collins, M.D.¹, Gurbakhash Kaur, MD^1*, Kiran A Kumar, MD, MBA^9*, Yazan F. Madanat, MD¹, Madhuri Vusirikala, MD^10*, Farrukh T. Awan, MD¹¹, Alagarraju Muthukumar, PhD^12* and Praveen Ramakrishnan Geethakumari, MD, MS¹⁰

¹Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
²Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Fort Worth, TX
³UT Southwestern Medical Center, Dallas, TX
⁴Department of Pharmacy, UT Southwestern Medical Center, Dallas, TX
⁵UT Southwestern Medical Center, Dallas, Dallas, TX
⁶Myeloma, Waldenstrom’s and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁷Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, dallas, TX
⁸Division of Hematology and Oncology, Department of Internal Medicine, Children's Research Institute, University of Texas Southwestern, Dallas, TX
⁹Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX
¹⁰Division of Hematologic Malignancies, UT Southwestern Medical Center, Dallas, TX
¹¹Division of Hematology and Oncology, The Ohio State University, Dallas, TX
¹²Department of Pathology, UT Southwestern Medical Center, Dallas, TX

Faouzi Djebbari^1*, Alexandros Rampotas^1*, Grant Vallance^1*, Fotios Panitsas^2*, Nanda Basker^3*, Gina Sangha^4*, Beena Salhan^5*, Farheen Karim^6*, Firas Al-Kaisi, MD^7*, Amy Gudger^8*, Loretta Ngu^9*, Matt Poynton^10*, Ho Pui Jeff Lam^11*, Lowri Morgan^12*, Laura Yang^13*, Jennifer Young^14*, Mairi Walker^15*, Ismini Tsagkaraki^16*, Laura Anderson^17*, Saleena Rani Chauhan^18*, Rebecca Maddams^19*, Richard Soutar^20*, Margarita Triantafillou^21*, Steve Prideaux^22*, Abubaker Obeidalla^23*, Ceri Bygrave^24*, Supratik Basu^25* and Karthik Ramasamy²⁶

¹Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
³University Hospital Southampton, Southampton, United Kingdom
⁴Milton Keynes Hospital, Milton Keynes, United Kingdom
⁵Birmingham Heartlands Hospital, Birmingham, ENG, United Kingdom
⁶The Royal Wolverhampton NHS Turst, Wolverhampton, United Kingdom
⁷Royal Derby Hospital, Derby, ENG, United Kingdom
⁸Queen Elizabeth Hospital, Birmingham, United Kingdom
⁹Royal Devon & Exeter NHS Foundation Trust, Exeter, United Kingdom
¹⁰Royal Berkshire Hospital, Reading, United Kingdom
¹¹Guy's and St Thomas NHS Foundation Trust, London, ENG, United Kingdom
¹²University Hospital of Wales, Cardiff, United Kingdom
¹³University Hospitals Sussex NHS Foundation Trust, Worthing, United Kingdom
¹⁴Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
¹⁵University Hospital Crosshouse, Crosshouse, United Kingdom
¹⁶Stoke Mandeville Hospital, Aylesbury, United Kingdom
¹⁷Royal United Hospital Bath, Bath, GBR
¹⁸Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom
¹⁹Poole Hospital, Poole, United Kingdom
²⁰Beatson Oncology Centre, Glasgow, United Kingdom
²¹Manchester Royal Infirmary, Manchester, United Kingdom
²²Great Western Hospital, Swindon, United Kingdom
²³Wexham Park Hospital, Slough, United Kingdom
²⁴Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom
²⁵The Royal Wolverhampton NHS Trust and University, West Midlands Research Consortium (WMRC), Wolverhampton, United Kingdom
²⁶Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Zhengrui Xiao, MD¹, Hieu Liem Le Nguyen^1*, Daming Shao^2* and Irina Murakhovskaya, MD³

¹Department of Hematology-Oncology, Montefiore Medical Center, Bronx, NY
²Department of Internal Medicine, Jacobi Medical Center, Bronx, NY
³Division of Hematology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Caroline LE Lan^1*, Aurelien Belot^2*, Camille Golfier, MD^3*, Berenice Audin^3*, Pierre Sesques, MD^3*, Adeline Bernier, PhD^2*, Violaine Safar, MD^3*, Alexandra Marquet^2*, Emmanuelle Ferrant, MD^3*, Anne Lazareth, MD^3*, Helene Lequeu, MD^3*, Fadhela Bouafia, MD^3*, Lionel Karlin^3*, Dana Ghergus, MD^3*, Alizee Maarek, MD^3*, Guillaume Aussedat^3*, Maryam Idlhaj^3*, Gilles Salles, MD, PhD⁴, Fanny Cherblanc, PhD^2*, Emmanuel Bachy, MD, PhD^3* and Herve Ghesquieres, MD, PhD^5*

¹Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, LYON, France
²LYSARC, The Lymphoma Academic Research Organisation, Lyon Sud University Hospital, Pierre Benite, France
³Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
⁴Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France

Rafael Fonseca¹, Diana Tran^2*, Emily Rosta^2*, Alyshia Laidlaw^2*, Manvir Rai^2*, Joana Duran^3* and Eric M. Ammann^4*

¹Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ
²EVERSANA, Burlington, ON, Canada
³Janssen Global Medical Affairs, Raritan, NJ
⁴Janssen Global Services, LLC, Market Access, Raritan, NJ

Jennifer S Harper^1*, Alex Z. Fu^1,2*, Dee Lin^3*, Bingcao Wu^3*, Nina Kim^3*, Savanna Ledford^3* and Sundar Jagannath⁴

¹Real World Research, Janssen Scientific Affairs, LLC, Titusville, NJ
²Department of Oncology, Georgetown University Medical Center, Washington, DC
³Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA
⁴Icahn School of Medicine at Mount Sinai, New York, NY

Tondre T. Buck, MD^1*, Taylor Salinardi, PhD^2* and Megan S. Rice, ScD, MPH^2*

¹Center for Hematology/Oncology, Spartanburg Medical Center, Spartanburg
²Sanofi, Cambridge, MA

Aneeqa A Zafar^1*, Chiung-Yu Huang, PhD^2*, Mimi Lo, PharmD, BCPS, BCOP^3*, Jen Knoche, BSN, RN^1*, Shagun Arora, MD⁴, Alfred Chung, MD⁴, Sandy W. Wong, MD⁴, Jeffrey L. Wolf, MD⁴, Thomas Martin, MD⁴, Nina Shah, MD⁵ and Rahul Banerjee, MD^1,6

¹University of California San Francisco, San Francisco, CA
²Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA
³Department of Pharmaceutical Services, University of California San Francisco, San Francisco, CA
⁴Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
⁵Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
⁶Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA

Christopher E. Jensen, MD^1,2, Tzy-Mey Kuo, PhD, MPH^3*, Matthew Leblanc, PhD, BSN, RN^4*, Chris D Baggett, PhD^3*, Xi Zhou^3*, Katherine E Reeder-Hayes^4,5* and Jennifer L Lund, PhD^6*

¹Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC
²Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC
³Cancer Information & Population Health Resource, University of North Carolina at Chapel Hill, Chapel Hill, NC
⁴Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁵Division of Oncology, University of North Carolina School of Medicine, Chapel Hill, NC
⁶Department of Epidemiology, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, NC

Ghulam Rehman Mohyuddin, MD¹, Rajshekhar Chakraborty, MD², Gregory Calip, PhD^3*, Mustafa S Ascha, PhD, MS^4*, Xiaoliang Wang, PhD, MPH^5*, Samuel Rubinstein, MD^6*, Sascha A. Tuchman, MD, MHS⁷, Luciano J. Megala Costa, MD, PhD⁸, Benjamin Haaland^9*, Smith Giri, MD, MHS¹⁰, Hira S Mian, MD¹¹, Rafael Fonseca¹² and Douglas W. Sborov, MD¹³

¹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT
²Department of Medicine, Columbia University Irving Medical Center, Thornwood, NY
³Flatiron Health Inc, New York, NY
⁴Flatiron Health, New York, NY
⁵Flatiron Health Inc., New York, NY
⁶Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, NC
⁷Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
⁸University of Alabama at Birmingham Hospital, Vestavia, AL
⁹University of Utah, Salt Lake City
¹⁰Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
¹¹Department of Oncology, McMaster University, Hamilton, ON, Canada
¹²Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
¹³Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT

Laurent Garderet, MD, PhD¹, Luuk Gras^2*, Linda Koster^3*, Anita D'Souza, MD, MS⁴, Noel Estrada-Merly^5*, Parameswaran Hari, MD, MRCP⁶, Wael Saber, MD, MS⁵, Andrew J Cowan, MD⁷, Minako Iida, MD, PhD^8*, Shinichiro Okamoto, MD, PhD⁹, Hiroyuki Takamatsu, MD, PhD¹⁰, Shohei Mizuno, MD, PhD^11*, Koji Kawamura^12*, Yoshihisa Kodera, MD^13*, Nada Hamad, MBBS, BSc, MSc¹⁴, Bor-Sheng Ko, MD, PhD^15*, Christopher Liam¹⁶, Kim Wah Ho, MBBS, MRCP^17*, A Sim Goh^18*, S Keat Tan^18*, Alaa M. Elhaddad, MD¹⁹, Ali Bazarbachi, MD, PhD²⁰, Qamar un Nisa Chaudhry^21*, Rozan Alfar, MBBS^22*, Mohamed-Amine Bekadja^23*, Malek Benakli, MD, PhD²⁴, Cristobal Augusto Frutos Ortiz, MD^25*, Eloisa Riva, MD, MEd²⁶, Sebastian Galeano, MD²⁷, Francisca Bass, MD^28*, Hira S Mian, MD²⁹, Arleigh McCurdy, MD, BSc³⁰, Feng Rong Wang^31*, Daniel Neumann^32*, Mickey Koh, MD, PhD^33*, John A Snowden³⁴, Stefan Schönland^35*, Donal P. McLornan, MD, PhD^36*, Patrick John Hayden, MD³⁷, Anna Sureda³⁸, Hildegard T. Greinix, MD³⁹, Mahmoud Aljurf, MD⁴⁰, Yoshiko Atsuta^41* and Dietger Niederwieser, MD⁴²

¹Service Hematologie, Sorbonne Université, Hopital Pitié Salpêtière APHP, Paris, France
²EBMT Statistical Unit, Leiden, The Netherlands, Leiden, Netherlands
³EBMT Data Office, Leiden, Netherlands
⁴Department of medicine, medical college of Wisconsin, Milwaukee
⁵CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁶Medical College of Wisconsin, Milwaukee, WI
⁷Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁸Aichi Medical University School of Medicine, Nagakute-cho, Aichi, JPN
⁹Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
¹⁰​School of Entrepreneurial and Innovation Studies, Kanazawa University, Kanazawa, Japan
¹¹Department of Hematology, Aichi Medical University School of Medicine, Nagakute, AIC, Japan
¹²Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, SAI, Japan
¹³Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagoya, Japan
¹⁴Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
¹⁵National Taiwan University Hospital, Taipei, Taiwan
¹⁶Hospital Ampang, Ampang, Selangor, Malaysia
¹⁷Department of Hematology, Ampang Hospital, Ampang, Malaysia
¹⁸Penang general hospital, Penang, Malaysia
¹⁹Department of Pediatric Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Cairo University, Cairo, Egypt
²⁰American University of Beirut Dept. of Medicine, Beirut, Lebanon
²¹AFBMTC/NIBMT, Rawalpindi, Pakistan
²²King Hussein cancer center, Amman, ON, Jordan
²³Department of Hematology and Cell Therapy, EHU 1st Novembre 1954 Bir el Djir Usto, University Ahmed Benbella 1, Oran, Algeria
²⁴Centre Pierre et Marie Curie (CPMC), Algiers, Algeria
²⁵Hospital Central Del Instituto De Prevision Social, Asuncion, Paraguay
²⁶Cátedra de Hematología, Hospital de Clínicas, Facultad de Medicina, Montevideo, Montevideo, Uruguay
²⁷Hematology Department, British Hospital, Montevideo, Montevideo, Uruguay
²⁸Hospital del Salvador, Santiago, Chile
²⁹Department of Oncology, McMaster University, Hamilton, ON, Canada
³⁰Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
³¹Peking University, Beijing, China
³²IMISE, university of Leipzig, Leipzig, Germany
³³Department of Haematology, St George's Hospital NHS Foundation Trust, London, United Kingdom
³⁴BSBMTCT, Department of Haematology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom
³⁵Department of Internal Medicine V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
³⁶Department of Haematology, Kings's College Hospital, London, ENG, United Kingdom
³⁷Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin 8, Leinster, Ireland
³⁸Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain
³⁹Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
⁴⁰Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
⁴¹Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
⁴²University of Leipzig, Leipzig, Germany

Mitchell R Smith, MD¹, Julie Dodds, PhD^2*, Hetal Shah, MEng^3*, Zoe Drymoussi^2*, David Kennard, MBA, PhD^3* and Steven Labkoff, MD^4*

¹The Follicular Lymphoma Foundation, Washington, DC
²The Follicular Lymphoma Foundation, London, ENG, United Kingdom
³The Follicular Lymphoma Foundation, London, United Kingdom
⁴Quantori, Cambridge, MA

Ulf-Henrik Mellqvist¹, Qian Cai^2*, Laura L Hester^3*, Michael Grövdal^4*, Jakob Börsum^5*, Iffat Rahman^6*, Eric M. Ammann^7* and Markus Hansson^8*

¹Sahlgrenska University Hospital, Boras, Sweden
²Janssen Pharmaceuticals, Horsham, PA
³Janssen Pharmaceuticals, Titusville, NJ
⁴Janssen Pharmaceuticals, Stockholm, Sweden
⁵SDS Life Science, Uppsala, Sweden
⁶SDS Life Science, Danderyd, Sweden
⁷Janssen Global Services, LLC, Market Access, Raritan, NJ
⁸Sahlgrenska Academy, Göteborg University and Sahlgrenska University Hospital, Skåne University Hospital, Lund, Sweden

Patrick Connor Johnson, MD¹, Tejaswini Dhawale, MD^2,3, Mitchell W. Lavoie^3*, Kyle Karpinski, BS^3*, Netana H. Markovitz, MD^4*, Kathleen Hennessey^3*, Matthew Frigault, MD, MS³ and Areej El-Jawahri, MD³

¹Cancer Center, Massachusetts General Hospital, Boston, MA
²Harvard Medical School, Boston, MA
³Massachusetts General Hospital, Boston, MA
⁴Beth Israel Deaconess Medical Center, Boston, MA

Ephrem Sedeta, MD, MSc.¹, Nosakhare Ilerhunmwuwa^1*, Mustafa Wasifuddin, MD^1*, Ifeanyi Uche, MBBS^1*, Narek Hakobyan, MD^1*, Jamal Perry, MD^1*, Henry Aiwuyo, MD^1*, Hesham Abowali, MD^2* and Boris Avezbakiyev, MD^2*

¹Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
²Division of Hematology and Medical Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY

Austin L Brown, MPH, PhD^1,2*, Heidi V Russell, MD, PhD^3*, Abiodun Oluyomi, PhD^4*, Michelle Fritsch, MSW^1*, Kayla Foster, MD^1,2*, Omar Shakeel, MD^1,2, Shawki Lotfi Qasim, MD^1,2*, Fatih Okcu, MD^1,2* and Maria Monica Gramatges, MD, PhD⁵

¹Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX
²Department of Pediatrics, Baylor College of Medicine, Houston, TX
³School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX
⁴Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX
⁵Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX

Poorva Bindal, MD¹, Pavania Elavalakanar, MSc, BSc^1*, Caitlin A. Trottier, MD^2*, Laura E. Dodge, ScD MPH^1,3*, Emma K. Logan^1*, David J. Sermer, MD¹, Michael Leukam, MD, MS¹, Matthew J Weinstock, MD¹, Robin M. Joyce, MD¹, Jessica Liegel, MD¹, Jacalyn Rosenblatt, MD¹, David Avigan, MD¹, Carolyn D. Alonso, MD^1* and Jon E. Arnason, MD¹

¹Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
²Tufts Medical Center, Boston, MA
³Harvard T.H. Chan School of Public Health, Boston, MA

Tycel Phillips, MD^1*, Junhua Yu, PhD^2*, Rajesh Kamalakar, MS^3*, Kalatu R. Davies, PhD^3*, Alex Mutebi, PhD^4*, Savreet Bains Chawla, MS^4*, Donald Arnette, PhD^3*, Syed Quadri, PharmD^3* and Anthony Wang, PhD, MPH^3*

¹University of Michigan, Ann Arbor, MI
²AbbVie Inc., North Chicago, IL
³AbbVie, Inc., North Chicago, IL
⁴Genmab, Princeton, NJ

Dee Lin^1*, Jordan Richardson^2*, Nina Kim^1*, Savanna Ledford^1*, Josh Feldman^2*, Paul Boyce^2* and Bingcao Wu^1*

¹Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA
²Inspire Insights, Inspire, Arlington, VA

Anthony J Messina, MSc^1,2, Rachel Byrd, MS^3*, Keri McDonough, MA^2*, Darcy R Flora, PhD^3*, Sam Schneider, BS^3*, Sara D Towne, PhD^2*, Julie Prock, BA^2*, Lynn Donald, BSc^2*, Dan Platt, MD^3* and Jane K Bentley, PhD^2*

¹Clinical Research and Leadership, George Washington University, Port St Lucie, FL
²Patient Voice Consortium, Syneos Health, Morrisville, NC
³Department of Research, GRYT Health, Rochester, NY

Nicole Watts, PharmD^1*, Courtney Hebert, PharmD^2*, Clare Ubersax, BS^3*, Deanna Clark, MBA, MPH^3*, Gayathri Ravi, MD⁴, Susan Bal, MD¹, Purnima Singh, PhD, MSc⁵, Kelly N. Godby, MD^6*, Donna Salzman, MD⁷, Luciano J. Megala Costa, MD, PhD¹, Grant Williams, MD, MPH^8*, Smita Bhatia, MD, MPH³ and Smith Giri, MD, MHS³

¹University of Alabama at Birmingham, Birmingham, AL
²Pharmacy, University of Alabama at Birmingham, Birmingham, AL
³Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
⁴Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
⁵Children's of Alabama Hospital, Birmingham, AL
⁶Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Hospital, Birmingham, AL
⁷Divison of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
⁸Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Sneha T Reddy, MD^1*, Larry A Saltzman, MD^1*, Louis J DeGennaro, PhD¹, Gwen L Nichols, MD¹, Janaela Scott^1*, Jonathon W Senefeld, PhD^2*, Patrick W Johnson^3* and Lee M Greenberger, PhD⁴

¹The Leukemia & Lymphoma Society, Rye Brook, NY
²Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN
³Mayo Clinic, Jacksonville, FL
⁴The Leukemia & Lymphoma Society, Montclair, NJ

Karen Sweiss, PharmD¹, Craig C Hofmeister, MD², John G. Quigley, MD, FRCP (C)³, Jaleel G. Sweis^4*, Kaily Kurzweil, PharmD^5*, Douglas W. Sborov, MD⁶, Lisa Sharp, PhD, BSN, MA^7*, Gregory S Calip, PharmD, MPH, PhD⁷, Lucas Maahs, MD³, Ana Maria Avila, MD³, Chukwuemeka Uzoka, MD³, Elizabeth Ilo^8*, Elliot Wolf^8*, Damiano Rondelli, MD³ and Pritesh Patel³

¹Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
²Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
³Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
⁴University of Jordan, Amman, Jordan
⁵Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL
⁶Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT
⁷Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL
⁸Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL